SCYNEXIS, Inc. , a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC).
Scynexis stock last closed at $0.92, up 1.77% from the previous day, and has decreased 36.11% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.21 percentage points. Scynexis stock is currently +26.37% from its 52-week low of $0.73, and -70.03% from its 52-week high of $3.07.
As of Apr 21, 2025, there are 38.98M SCYX shares outstanding. The market capitalization of SCYX is $35.86M. In the last 24 hours, 171,035 SCYX shares were traded.
How to Buy Scynexis Stock
Not sure how to invest in Scynexis stock? Here's how.
Choose where to buy Scynexis stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Scynexis stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your brokerage account: Select your payment method and add your information.
Analyze Scynexis stock: The Scynexis ticker symbol is SCYX. Is Scynexis stock a good investment? Should you buy shares of SCYX? How do SCYX's underlying business fundamentals look? Do top analysts think Scynexis is a good buy? Why has SCYX's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if SCYX is a good stock to buy).
Make your SCYX purchase: Decide if you will purchase SCYX shares at the current market price or use a limit order to buy SCYX stock at a particular price.
Track your SCYX position: Create a watchlist to get live updates on your new investment in Scynexis stock.
Step 1: Choose where to buy Scynexis stock
You need a brokerage account to access the NASDAQ market and buy SCYX shares.
A brokerage account is an investment account that enables you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the best brokerage, you need to fill out some personal information so you are able to buy SCYX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Scynexis stock
Once you have figured out the best place to buy Scynexis stock, it's absolutely critical to evaluate their stock before you invest, so you truly understand the risk and upside.
Scynexis stock at a glance
SCYX Price
$0.92
1w %
-6.79%
1y %
-36.11%
5y %
-89.58%
P/E
-2.09x
P/B
0.65x
P/S
11.95x
PEG
N/A
Revenue
$3.75M
Earnings
-$21.29M
Fore. Rev. Growth
153.97%
Fore. Earn. Growth
N/A
Market Cap
$35.86M
Next Earnings
May 6, 2025
Next Dividend
N/A
SCYX Due Diligence Score
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.
Last year, SCYX revenue was $3.75M. During the past five year, SCYX's revenue has increased by 98.68% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.89%.
Over the past year, executives and large shareholders at SCYX have bought more shares than they have sold.
Gonzalez David Angulo, Chief Executive Officer of SCYX, was the latest SCYX insider to buy. They bought $19,320.00 worth of SCYX shares on Apr 9, 2025.
No, Scynexis doesn't provide an income stream by paying out dividends.
What do other traders have to say about SCYX?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your SCYX purchase
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly sufficient.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular price limit, use a limit order.
Press the Open Trade button and your broker will place your order.
If you want more info about buying stocks on eToro, click the how to video below:
As of Apr 21, 2025, it costs $0.92 to buy one share of Scynexis stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.46, you can buy 0.5 shares of SCYX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.